2561 — Visen Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapSucker Stock

Annual balance sheet for Visen Pharmaceuticals, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—
Source:	PROSPECTUS	PROSPECTUS	ARS	PRESS
Standards:	HKAS	HKAS	HKAS	—
Status:	Final	Final	Final	Final
Cash
Cash and Equivalents
Cash and Short Term Investments	626	348	204	633
Net Total Accounts Receivable
Net Total Receivables	70.6	13.5	9.57	247
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	712	374	223	942
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	17.2	13.3	11.2	7.7
Net Intangible Assets
Long Term Notes Receivable
Other Long Term Assets
Total Assets	741	444	294	977
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	87.3	51.8	52.2	211
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Liabilities	88.7	52.9	52.5	215
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	653	391	241	762
Total Liabilities & Shareholders' Equity	741	444	294	977
Total Common Shares Outstanding